Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application: Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus

Text

---

 

Federal Register: October 2, 2009 (Volume 74, Number 190)

Notices

Page 50960

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr02oc09-26

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive

Licensing of U.S. Provisional Patent Application Concerning Monoclonal

Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/239,266 entitled ``Monoclonal Antibodies Against Glycoprotein of

Ebola Sudan Boniface Virus,'' filed September 2, 2009. The United

States Government, as represented by the Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Material Command,

ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,

Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth

Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul

Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates generally to the field of antibodies. More specifically the invention relates to monoclonal antibodies against glycoproteins of the Ebola Sudan Boniface virus and methods of producing and using the same.

Brenda S. Bowen,

Army Federal Register Liaison Officer.

FR Doc. E9-23769 Filed 10-1-09; 8:45 am

BILLING CODE 3710-08-P

---